Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer

Clinical trial NCT06197581 · RECRUITING

Trial details

NCT number: NCT06197581
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer, Familial Male Radiotherapy; Complications Chemotherapeutic Toxicity Immune Checkpoint Inhibitor CDK4/6 Inhibitor Trastuzumab Pertuzumab PARP Inhibitor

Start date: 2024-01-12
Primary completion: 2026-01-15
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.